Sponsoring Agency HHS
    POP 6/1/11 - 5/31/18 (6 years)


The National Institute of Allergy and Infectious Diseases' (NIAID) Division of Microbiology and Infectious Diseases (DMID) has a requirement for developing and providing in vitro assays in order to advance the development of therapeutics for infectious diseases. Because of this, the DMID has awarded a Master IDIQ for the provision of services and resources for: advancing science by promoting cross-fertilization across and within disciplines and approaches; serving the research community more conveniently; achieving efficient use of resources through economy of scale and avoidance of duplication; and providing the flexibility needed to respond to changing priorities.

  • $20.2m Aggregate Dollars Obligated
  • $20.2m Aggregate Base & Exercised Options
  • $21.1m Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts